摘要
目的:探究改良跗骨窦切口解剖型锁定钢板内固定治疗SandersⅡ、Ⅲ型跟骨骨折临床效果及足功能恢复情况。方法:选取2017年1月-2019年1月本院收治的40例(40足)SandersⅡ、Ⅲ型跟骨骨折患者,根据随机数表法将其分为A组和B组,每组20例。A组采用改良跗骨窦切口解剖型锁定钢板内固定治疗,B组采用外侧"L"形切口内固定术治疗。比较两组临床指标、并发症发生情况及足功能恢复情况。结果:A组手术用时、切口长度均短于B组,术中出血量少于B组,差异均有统计出学意义(P<0.05)。两组近期并发症发生率比较,差异无统计学意义(P>0.05)。A组远期并发症发生率低于B组,差异有统计学意义(P<0.05)。A组足功能恢复优良率高于B组,差异有统计学意义(P<0.05)。结论:改良跗骨窦切口解剖型锁定钢板内固定治疗的手术用时少、创伤性小、安全性高、骨折愈合时间短,且可促进足功能恢复。
Objective:To explore the clinical effect of modified sinus tarsal incision and anatomical locking plate internal fixation in the treatment of Sanders Ⅱ,Ⅲ calcaneal fractures and analysis of the foot function recovery.Method:A total of 40 patients (40 feet) with calcaneal fractures of Sanders Ⅱ,Ⅲ type in our hospital from January 2017 to January 2019 were selected,and they were divided into group A and group B according to the random number table method,20 patients in each group.Group A was treated with modified sinus tarsal incision and anatomical locking plate internal fixation,group B was treated with external "L" incision internal fixation.The clinical indexes,incidence of complications and recovery of foot function recovery were compared between two groups.Result:The operation time and incision length of group A were shorter than those of group B,and the blood loss during operation of group A was less than that of group B,the differences were statistically significant (P<0.05).There was no significant difference in the incidence of recent complications between two groups (P>0.05).The incidence of long-term complications of the group A was lower than that of the group B,the difference was statistically significant (P<0.05).The total excellent and good rate of foot function recovery of the group A was higher than that of the group B,the difference was statistically significant (P<0.05).Conclusion:The modified sinus tarsal incision and anatomical locking plate internal fixation has less operation time,less trauma,high safety,short fracture healing time,and can promote the foot function recovery.
作者
黄朝荣
欧德阳
陈伟豪
黄政
莫建壕
邹镜宜
HUANG Zhaorong;OU Deyang;CHEN Weihao;HUANG Zheng;MO Jianhao;ZOU Jingyi(Zhaoqing First People’s Hospital,Zhaoqing 526060,China)
出处
《中国医学创新》
CAS
2021年第24期170-173,共4页
Medical Innovation of China
基金
肇庆市科技局项目(201804030833)。